Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. The company is headquartered in Sant Cugat Del Valles, Barcelona and currently employs 23,833 full-time employees. The company went IPO on 2006-05-17. The firm organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
Grifols, S.A. hisse başına yıllık % {var1} temettüye sahiptir ve % {var2} oranında bir getiri sunmaktadır. Temettü yıllık ödenmektedir ve son temettü hariç tarihi Aug 12, 2025 tarihindedir.
Dividend Yield
Yıllık Dividende
Özsermaye Tarihi
0.00%
$0.09
Aug 12, 2025
Ödeme Sıklığı
Ödeme Oranı
Yıllık
0.00%
Dividend History
Özsermaye Tarihi
Nakit Tutarı
Kayıt Tarihi
Ödeme Tarihi
Aug 12, 2025
$0.0879
Aug 12, 2025
Aug 20, 2025
Aug 12, 2025
$0.0867
Aug 12, 2025
Aug 20, 2025
Jun 3, 2021
$0.2221
Jun 4, 2021
Jun 14, 2021
Oct 30, 2020
$0.0948
Nov 2, 2020
Nov 9, 2020
Dec 2, 2019
$0.1109
Dec 3, 2019
Dec 11, 2019
Jun 7, 2019
$0.0821
Jun 10, 2019
Jun 18, 2019
Dividend Grafikleri
GIKLY Kâr Payları
GIKLY Dividend Growth (Yıllık Üstünlük)
Follow-Up Questions
Grifols, S.A.'in şu anki temettü ödemesi ve yıllık temettüsü nedir?